About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2012 (2012), Article ID 302894, 12 pages
http://dx.doi.org/10.1155/2012/302894
Review Article

Markers of Field Cancerization: Proposed Clinical Applications in Prostate Biopsies

1Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA
2New Mexico Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA

Received 6 February 2012; Accepted 8 March 2012

Academic Editor: Sandra M. Gaston

Copyright © 2012 Kristina A. Trujillo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [18 citations]

The following is the list of published articles that have cited the current article.

  • Brigitte N. Gomperts, Tonya C. Walser, Avrum Spira, and Steven M. Dubinett, “Enriching the Molecular Definition of the Airway "Field of Cancerization:" Establishing New Paradigms for the Patient at Risk for Lung Cancer,” Cancer Prevention Research, vol. 6, no. 1, pp. 4–7, 2013. View at Publisher · View at Google Scholar
  • M. L. Verschoor, R. Ungard, A. Harbottle, J. P. Jakupciak, R. L. Parr, and G. Singh, “Mitochondria and Cancer: Past, Present, and Future,” Biomed Research International, 2013. View at Publisher · View at Google Scholar
  • Peter H. Gann, Mahesh Mohnani, Erika Enk Rueter, Anup Amatya, Ryan Deaton, Yirong Yang, and Viju Ananthanarayanan, “Development of a Nuclear Morphometric Signature for Prostate Cancer Risk in Negative Biopsies,” Plos One, vol. 8, no. 7, 2013. View at Publisher · View at Google Scholar
  • G. Paolo Dotto, “Multifocal epithelial tumors and field cancerization: stroma as a primary determinant,” Journal of Clinical Investigation, vol. 124, no. 4, pp. 1446–1453, 2014. View at Publisher · View at Google Scholar
  • Ying Zhang, Thomas Perez, Beth Blondin, Jing Du, Ping Liu, Diana Escarzaga, John S. Coon, Larry E. Morrison, and Katerina Pestova, “Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Anna C. Jones, Kresta S. Antillon, Shannon M. Jenkins, Sara N. Janos, Heidi N. Overton, Dor S. Shoshan, Edgar G. Fischer, Kristina A. Trujillo, and Marco Bisoffi, “Prostate Field Cancerization: Deregulated Expression of Macrophage Inhibitory Cytokine 1 (MIC-1) and Platelet Derived Growth Factor A (PDGF-A) in Tumo,” Plos One, vol. 10, no. 3, 2015. View at Publisher · View at Google Scholar
  • Jasmeet Assi, Gunjan Srivastava, Ajay Matta, Christina MacMillan, Ranju Ralhan, and Paul G. Walfish, “Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas,” Plos One, vol. 10, no. 2, pp. e0107586, 2015. View at Publisher · View at Google Scholar
  • Hemant K. Roy, Charles B. Brendler, Hariharan Subramanian, Di Zhang, Charles Maneval, John Chandler, Leah Bowen, Karen L. Kaul, Brian T. Helfand, Chi-Hsiung Wang, Margo Quinn, Jacqueline Petkewicz, Michael Paterakos, and Vadim Backman, “Nanocytological Field Carcinogenesis Detection to Mitigate Overdiagnosis of Prostate Cancer: A Proof of Concept Study,” Plos One, vol. 10, no. 2, 2015. View at Publisher · View at Google Scholar
  • Hanibal Hani Adamo, Kerstin Stromvall, Maria Nilsson, Sofia Halin Bergstrom, and Anders Bergh, “Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness,” Plos One, vol. 10, no. 11, 2015. View at Publisher · View at Google Scholar
  • Maria Nilsson, Christina Hagglof, Peter Hammarsten, Elin Thysell, Par Stattin, Lars Egevad, Torvald Granfors, Emma Jernberg, Pernilla Wikstrom, Sofia Halin Bergstrom, and Anders Bergh, “High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting,” Plos One, vol. 10, no. 10, 2015. View at Publisher · View at Google Scholar
  • Alex Stepan, Cristiana Simionescu, Daniel Pirici, Raluca Ciurea, and Claudiu Margaritescu, “Fractal Analysis and the Diagnostic Usefulness of Silver Staining Nucleolar Organizer Regions in Prostate Adenocarcinoma,” Analytical Cellular Pathology, vol. 2015, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • Sofia Halin Bergström, Maria Nilsson, Hanibal Adamo, Elin Thysell, Emma Jernberg, Pär Stattin, Anders Widmark, Pernilla Wikström, and Anders Bergh, “Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth,” Plos One, vol. 11, no. 6, pp. e0157280, 2016. View at Publisher · View at Google Scholar
  • Ilinca Georgescu, Robert J. Gooding, R. Christopher Doiron, Andrew Day, Shamini Selvarajah, Chris Davidson, David M. Berman, and Paul C. Park, “Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes,” Cancer & Metabolism, vol. 4, no. 1, 2016. View at Publisher · View at Google Scholar
  • Benjamin A. Rybicki, Andrew Rundle, Oleksandr N. Kryvenko, Nicoleta Mitrache, Kieu C. Do, Michelle Jankowski, Dhananjay A. Chitale, Sheri Trudeau, Steven A. Belinsky, and Deliang Tang, “Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer,” International Journal of Cancer, vol. 138, no. 12, pp. 2884–2893, 2016. View at Publisher · View at Google Scholar
  • Adam Kowalewski, Łukasz Szylberg, Anna Skórczewska, and Andrzej Marszałek, “Diagnostic difficulties with atrophy, atypical adenomatous hyperplasia (AAH) and atypical small acinar proliferation (ASAP). A Systematic Review of Current Literature,” Clinical Genitourinary Cancer, 2016. View at Publisher · View at Google Scholar
  • P. Janeth Fernandez, Stelia C. Méndez-Sánchez, C.A. Gonzalez-Correa, and David A. Miranda, “Could Field Cancerization be Interpreted as A Biochemical Anomaly Amplification due to Transformed Cells?,” Medical Hypotheses, 2016. View at Publisher · View at Google Scholar
  • Elisa Pin, Steven Stratton, Claudio Belluco, Lance Liotta, Ray Nagle, K. Alex Hodge, Jianghong Deng, Ting Dong, Elisa Baldelli, Emanuel Petricoin, and Mariaelena Pierobon, “A Pilot Study Exploring the Molecular Architecture of the Tumor Microenvironment in Human Prostate Cancer Using a Laser Capture Microdissection and Reverse Phase Protein Microarray Workflow,” Molecular Oncology, 2016. View at Publisher · View at Google Scholar
  • Kerstin Strömvall, Elin Thysell, Sofia Halin Bergström, and Anders Bergh, “Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis,” Plos One, vol. 12, no. 5, pp. e0176679, 2017. View at Publisher · View at Google Scholar